Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Diagnosing Sertoli-Leydig cell tumors is challenging due to their unusual symptoms and can occur at any age.

Different body areas in mice produce different hair types due to interactions between skin layers.

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

Retinoic acid can change skin development, like turning scales into feathers or forming glands.

Hox proteins help maintain keratinocyte identity by regulating miRNA expression.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Estrogen affects scalp cell types differently, enhancing some wound healing processes.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Stem cell differentiation is crucial for skin barrier maintenance and its disruption can lead to skin diseases.

Moxibustion may help improve ovarian function by changing androgen levels.

Finasteride can help induce ovulation and lead to a healthy birth in some women.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Female guinea pigs exposed to less allopregnanolone before birth showed more anxiety-like behavior.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Ornithine decarboxylase is crucial for hair growth and follicle development.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.